Mazzilli Rossella, Cimadomo Danilo, Vaiarelli Alberto, Capalbo Antonio, Dovere Lisa, Alviggi Erminia, Dusi Ludovica, Foresta Carlo, Lombardo Francesco, Lenzi Andrea, Tournaye Herman, Alviggi Carlo, Rienzi Laura, Ubaldi Filippo Maria
Andrology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, University of Rome "Sapienza," Rome, Italy; Clinica Valle Giulia, Genera Centers for Reproductive Medicine, Rome, Italy.
Clinica Valle Giulia, Genera Centers for Reproductive Medicine, Rome, Italy; Dipartimento di Scienze Anatomiche, Istologiche, Medico-Legali e dell'Apparato Locomotore, Sezione Istologia ed Embriologia Medica, "Sapienza," University of Rome, Rome, Italy.
Fertil Steril. 2017 Dec;108(6):961-972.e3. doi: 10.1016/j.fertnstert.2017.08.033. Epub 2017 Oct 3.
To evaluate the impact of the male factor on the outcomes of intracytoplasmic sperm injection (ICSI) cycles combined with preimplantation genetic testing for aneuploidies (PGT-A).
Observational longitudinal cohort study.
Private in vitro fertilization (IVF) center.
PATIENT(S): A total of 1,219 oocyte retrievals divided into five study groups according to sperm parameters: normozoospermia (N), moderate male factor (MMF), severe oligoasthenoteratozoospermia (OAT-S), obstructive azoospermia (OA), and nonobstructive azoospermia (NOA).
INTERVENTION(S): ICSI with ejaculated/surgically retrieved sperm, blastocyst culture, trophectoderm-based quantitative polymerase chain reaction PGT-A, and frozen-warmed euploid embryo transfer (ET).
MAIN OUTCOMES MEASURE(S): The primary outcome measures were fertilization, blastocyst development, and euploidy rates; the secondary outcome measures were live birth and miscarriage rates. Perinatal and obstetrical outcomes were monitored as well.
RESULT(S): A total of 9,042 metaphase II oocytes were inseminated. The fertilization rate was significantly reduced in MMF, OAT-S, OA, and NOA compared with N (74.8%, 68.7%, 67.3%, and 53.1% vs. 77.2%). The blastocyst rate per fertilized oocyte was significantly reduced in MMF and NOA compared with N (48.6% and 40.6% vs. 49.3%). The timing of blastocyst development also was affected in OA and NOA. Logistic regression analysis adjusted for confounders highlighted NOA as a negative predictor of obtaining an euploid blastocyst per OPU (odds ratio 0.5). When the analysis was performed per obtained blastocyst, however, no correlation between male factor and euploidy rate was observed. Embryo transfers also resulted in similar live birth and miscarriage rates. No impact of sperm factor on obstetrical/perinatal outcomes was observed.
CONCLUSION(S): Severe male factor impairs early embryonic competence in terms of fertilization rate and developmental potential. However, the euploidy rate and implantation potential of the obtained blastocysts are independent from sperm quality.
评估男性因素对卵胞浆内单精子注射(ICSI)周期联合胚胎植入前非整倍体基因检测(PGT-A)结局的影响。
观察性纵向队列研究。
私立体外受精(IVF)中心。
根据精子参数将总共1219次取卵分为五个研究组:正常精子症(N)、中度男性因素(MMF)、重度少弱畸精子症(OAT-S)、梗阻性无精子症(OA)和非梗阻性无精子症(NOA)。
使用射出/手术获取的精子进行ICSI、囊胚培养、基于滋养外胚层的定量聚合酶链反应PGT-A以及冻融整倍体胚胎移植(ET)。
主要观察指标为受精率、囊胚发育率和整倍体率;次要观察指标为活产率和流产率。还监测围产期和产科结局。
总共9042个中期II卵母细胞进行了授精。与N组相比,MMF、OAT-S、OA和NOA组的受精率显著降低(分别为74.8%、68.7%、67.3%和53.1%,而N组为77.2%)。与N组相比,MMF和NOA组每个受精卵母细胞的囊胚率显著降低(分别为48.6%和40.6%,而N组为49.3%)。OA和NOA组的囊胚发育时间也受到影响。对混杂因素进行校正的逻辑回归分析突出显示NOA是每次取卵获得整倍体囊胚的负性预测因素(优势比为0.5)。然而,当按获得的囊胚进行分析时,未观察到男性因素与整倍体率之间的相关性。胚胎移植的活产率和流产率也相似。未观察到精子因素对产科/围产期结局有影响。
严重男性因素在受精率和发育潜能方面损害早期胚胎能力。然而,获得的囊胚的整倍体率和着床潜能与精子质量无关。